Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
3.050
-0.180 (-5.57%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aprea Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 17 | 18 | 18 | - | - |
| Market Cap Growth | -4.05% | 0.11% | - | - | - |
| Enterprise Value | -10 | -6 | -12 | - | - |
| Last Close Price | 3.05 | 4.70 | 6.62 | - | - |
| PS Ratio | 11.53 | 30.11 | - | - | - |
| PB Ratio | 0.76 | 0.96 | 0.65 | - | - |
| P/TBV Ratio | 0.68 | 1.04 | 0.68 | - | - |
| Debt / Equity Ratio | - | - | - | 0.00 | - |
| Asset Turnover | 0.05 | 0.02 | - | - | - |
| Quick Ratio | 7.22 | 4.93 | 8.99 | 7.25 | - |
| Current Ratio | 7.28 | 5.14 | 9.42 | 7.73 | - |
| Return on Equity (ROE) | -60.22% | -63.19% | -294.69% | - | - |
| Return on Assets (ROA) | -35.06% | -36.62% | -53.71% | - | - |
| Return on Capital (ROIC) | -41.15% | -42.77% | -60.94% | - | - |
| Earnings Yield | -81.48% | -81.35% | -642.23% | - | - |
| FCF Yield | -83.30% | -69.87% | -142.58% | - | - |
| Buyback Yield / Dilution | -47.99% | -118.32% | -55.69% | -0.72% | - |
| Total Shareholder Return | -47.99% | -118.32% | -55.69% | -0.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.